By using DiabetesTimes.co.uk, you agree to our terms and use of cookies to enhance your experience.

Roche ‘committed’ to diabetes

By Editor
1st February 2017
Latest news, Medical devices Pharmaceutical Self-monitoring of blood glucose

Roche has said it remains “committed to diabetes care” amid reports the Swiss firm is considering selling its diabetes division.

Speculation suggested Roche Holding AG was looking at options for its Diabetes Care business including a sale

But a spokesman for the group, which has its headquarters in Basel, said on Wednesday, January 31: “We remain committed to Diabetes Care.”

There was a report form Bloomberg saying Roche was considering alternatives for the unit including a partial sale or spinoff. The news outlet said the sale could reach up to $5 billion.

The company’s UK base is in Burgess Hill, West Sussex, and it employs more 150 people across the UK and Ireland. It produces blood glucose monitoring systems, including the Accu-Chek brand.

Last week Johnson & Johnson said was seeking a possible sale, joint venture or operating partnerships for LifeScan Inc.

In 2015, Bayer AG sold its diabetes arm to KKR and Panasonic for $1.1 billion.

Comments (0)

Register an account or login to comment